Unlocking Tumor Eradication with Antibodies-MHC T-Cell Engagers
Time: 5:15 pm
day: Conference Day One
Details:
• Discuss how antibodies targeting tumor peptides on the MHC enable T-cells access to an untapped reservoir of intracellular tumor antigens
• Explore the synergy of our proprietary antibody-MHC platform to develop highly specific T-cell engagers for targeting tumors
• Highlight the potential of leveraging the potency, versatility and manufacturability of antibodies to target tumor peptides on the MHC, revolutionizing cancer immunotherapy
